PLoS ONE
(Jan 2024)
Protocol for a seamless phase 2A-phase 2B randomized double-blind placebo-controlled trial to evaluate the safety and efficacy of benfotiamine in patients with early Alzheimer’s disease (BenfoTeam)
Howard H. Feldman,
José A. Luchsinger,
Gabriel C. Léger,
Curtis Taylor,
Diane M. Jacobs,
David P. Salmon,
Steven D. Edland,
Karen Messer,
Carolyn Revta,
Sarah A. Flowers,
Kerry S. Jones,
Albert Koulman,
Kevin E. Yarasheski,
Philip B. Verghese,
Venky Venkatesh,
Henrik Zetterberg,
January Durant,
Jody-Lynn Lupo,
Gary E. Gibson
Affiliations
Howard H. Feldman
José A. Luchsinger
Gabriel C. Léger
Curtis Taylor
Diane M. Jacobs
David P. Salmon
Steven D. Edland
Karen Messer
Carolyn Revta
Sarah A. Flowers
Kerry S. Jones
Albert Koulman
Kevin E. Yarasheski
Philip B. Verghese
Venky Venkatesh
Henrik Zetterberg
January Durant
Jody-Lynn Lupo
Gary E. Gibson
Journal volume & issue
Vol. 19,
no. 5
WeChat QR code
Close